A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
This protocol outlines a rapid method to simultaneously generate melanocyte and fibroblast cultures from the skin of 0-4 day old mice. These primary cultures can be maintained and manipulated in vitro to study a variety of physiologically relevant processes, including skin cell biology, pigmentation, wound healing and melanoma.
Defects in fibroblast or melanocyte function are associated with skin diseases, including poor barrier function, defective wound healing, pigmentation defects and cancer. Vital to the understanding and amelioration of these diseases are experiments in primary fibroblast and melanocyte cultures. Nevertheless, current protocols for melanocyte isolation require that the epidermal and dermal layers of the skin are trypsinized and manually disassociated. This process is time consuming, technically challenging and contributes to inconsistent yields. Furthermore, methods to simultaneously generate pure fibroblast cultures from the same tissue sample are not readily available. Here, we describe an improved protocol for isolating melanocytes and fibroblasts from the skin of mice on postnatal days 0-4. In this protocol, whole skin is mechanically homogenized using a tissue chopper and then briefly digested with collagenase and trypsin. Cell populations are then isolated through selective plating followed by G418 treatment. This procedure results in consistent melanocyte and fibroblast yields from a single mouse in less than 90 min. This protocol is also easily scalable, allowing researchers to process large cohorts of animals without a significant increase in hands-on time. We show through flow cytometric assessments that cultures established using this protocol are highly enriched for melanocytes or fibroblasts.
Mammalian skin is a multilayered organ that protects the body from foreign pathogens and ultra violet irradiation (UVR). The skin also plays a critical role in homeostatic processes such as wound healing, temperature regulation and vitamin D production1,2,3. Mammalian skin consists of three major cell types: melanocytes, fibroblasts and keratinocytes. These cell types populate different layers of the skin, with keratinocytes making up the epidermis, fibroblasts residing in the dermis and melanocytes localizing to the epidermal-dermal junction and hair follicles4. Here, we detail a simple procedure that enables the concurrent generation of primary melanocyte and fibroblast cultures from murine skin.
Melanocytes are pigment-producing cells found in many locations throughout the human body, including the basal epidermis, iris, cochlea, brain and hair follicles5. The primary function of melanocytes is to generate and secrete melanin-containing vesicles called melanosomes5,6. Melanosomes contain two major classes of melanin: brown/black eumelanin and yellow/red pheomelanin6,7. Biochemical processes within the melanocyte regulate the relative abundance of each melanin species and help to determine hair, skin and eye color8,9. Melanin also serves to absorb UVR and protect sun-exposed tissues from mutagenesis10.
Melanocyte dysfunction can cause pigmentary defects and increase skin cancer susceptibility. For example, the hyper-pigmented skin patches characteristic of melasma are the result of focal melanin overproduction, whereas germline genetic mutations which compromise genes involved in melanin synthesis lead to albinism11,12. Intimate knowledge of melanocyte biology is required to develop strategies that will correct such pigmentary defects and ultimately improve the psychosocial well-being of individuals afflicted with these diseases. Deficits in melanin production and/or the preferential synthesis of pheomelanin are also associated with increased skin cancer risk10. This risk is believed to result from reduced UVR protection6,13. Thus, methods to enhance or restore eumelanin production in melanocytes may reduce the incidence of skin cancer in these populations.
Mesenchymal fibroblasts establish the connective tissue and structural support for all organs of the body, including the dermal layer of the skin14. Excretion of proteins such as collagen, elastin, laminin and fibronectin enable fibroblasts to form the extracellular matrix (ECM) that is essential for tissue integrity1,14. Fibroblasts also play essential roles in processes such as wound healing, inflammation, angiogenesis and cancer formation/progression1,15,16.
Similar to melanocytes, defects in fibroblast activation and function can promote tumorigenesis and disease. For example, inappropriate fibroblast activation commonly leads to the formation of fibrosis, resulting from the enhanced deposition of excess ECM components into the surrounding tissue. As fibroblasts maintain much of the body’s structural integrity, fibrosis promotes diseases that affect numerous tissues and organs, including idiopathic pulmonary fibrosis, systemic sclerosis, liver cirrhosis and cardiac fibrosis15. Fibroblasts also play a critical role in cancer16. Cancer associated fibroblasts (CAFs) are the most abundant non-malignant cells in the microenvironment of many tumors. CAFs have been shown to promote tumor proliferation, progression and therapeutic resistance by modulating tissue stiffness, local cytokine production and immune function16.
Primary cell cultures provide researchers with genetically tractable models to identify and mitigate melanocyte and fibroblast defects that lead to disease. However, current methods to establish melanocyte cultures are time consuming and technically challenging. The need for trypsinization and delicate separation of the epidermis and dermis contributes to variability in experimental yield and makes it difficult to perform large-scale experiments. Furthermore, protocols to simultaneously isolate melanocytes and fibroblasts from whole skin are currently lacking in the field.
We have developed a method to reduce the processing steps, variability and time required to establish melanocyte and fibroblast cultures from the same whole skin sample. Using a mechanical homogenization method followed by a brief digestion, our strategy significantly decreases the amount of hands-on time required to isolate primary melanocytes while enabling concurrent fibroblast isolation. The increased speed, efficiency and consistency of this protocol, in combination with the ability to isolate melanocytes from 0-4 day old mice, provides researchers the flexibility to perform a wider array of experiments than previously possible.
Obtain approval from your institutional animal ethics committee before commencing this or any other study involving animals. Experiments performed in this protocol were approved by the Ohio State University’s Institutional Animal Care and Use Committee (IACUC, protocol #2012A00000134).
1. Protocol Preparation
NOTE: The following reagent preparation instructions are appropriate for the generation of 9 cm2 melanocyte and fibroblast cultures from a single mouse. Refer to the reagent preparation guide in Table 1 for larger scale isolations.
2. Melanocyte and Fibroblast Isolation
3. Confirmation of Cellular Purity
Male and female C57Bl/6J mice were euthanized on postnatal days 0-4 and the truncal skin was subjected to mechanical dissociation as described above. After chopping, the skin formed a viscous slurry lacking any sign of structural tissue. Centrifugation of this slurry resulted in the formation of a large cell pellet at the bottom of the conical tube and a layer of adipose floating on top of the supernatant. This adipose layer was discarded with the supernatant while the remaining cell pellet was resuspended and transferre...
The in vitro culture of primary melanocytes and fibroblasts has led to significant advancements in our understanding of skin biology and disease. This protocol improves upon prior melanocyte isolation methods by reducing the time and technical savvy needed to generate consistent melanocyte cultures while allowing for the simultaneous isolation of skin fibroblasts. A novel, time-saving element of this procedure is that the dermis and epidermis do not need to be separated. Instead, skin cells are isolated using the consist...
The authors have no conflicts of interest to disclose.
The authors thank the Damon Runyon Foundation (Innovation Award #38-16 to C.E.B.) and Pelotonia (B.M.M.) for financial support. We are grateful to C. Haines and C. Wormsbaecher who provided comments to improve the manuscript text. This work benefitted from the Ohio State Comprehensive Cancer Center’s Analytical Cytometry Shared Resource which is supported by NIH P30 CA016058.
Name | Company | Catalog Number | Comments |
0.2 µm PES sterile syringe filter | VWR | 28145-501 | |
10 cm cell culture dish | Corning | 430167 | |
40 µm cell strainer | Fisher Scientific | 22363547 | |
5 mL polystyrene round-bottom tubes | Fisher Scientific | 352008 | |
6-well cell culture dish | Sigma-Aldrich | SIAL0516 | |
70 µm cell strainer | Fisher Scientific | 22363548 | |
Antibiotic Antimycotic Solution (100x) | Sigma-Aldrich | A5955 | |
Bovine Serum Albumin | Fisher Scientific | BP9706-100 | |
CF 488A Mix-n-Stain Antibody Labeling Kit | Biotium | 92273 | |
CF 555 Mix-n-Stain Antibody Labeling Kit | Biotium | 92274 | |
Cholera Toxin | Sigma-Aldrich | C8052 | |
Collagen from rat tail | Sigma-Aldrich | C7661 | |
Collagenase Type I | Worthington Biochemicals | LS004156 | |
Corning Penicillin/Streptomycin Solution | Fisher Scientific | 30-002-CL | |
Cytokeratin 14 Antibody Alexa Fluor 647 | Novus Biologicals | NBP2-34403AF647 | |
Deoxyribonuclease I | Worthington Biochemicals | LS002058 | |
Di-butyryl cyclic AMP | Sigma-Aldrich | D0627 | |
Dulbecco's Modified Eagle Medium | Gibco | 12800-082 | |
Dulbecco's Phosphate Buffered Saline | Sigma-Aldrich | D8537 | |
eBioscience Fixable Viability Dye eFluor 780 | Thermo Fisher | 65-0865-14 | |
Ethanol, 200 proof | Fisher Scientific | 22032601 | |
Fetal Bovine Serum | Sigma-Aldrich | 12306C | |
FSP1/S100A4 antibody | Millipore Sigma | 07-2274 | |
G418 Disulfide | P212121 | LGB-418-1 | |
Glacial Acetic Acid | VWR | VWRV0714 | |
Horse Serum | Fisher Scientific | 26050088 | |
HyClone L-Glutamine | Fisher Scientific | SH3003402 | |
McIlwain Tissue Chopper | Ted Pella | 10180 | |
Melanoma gp100 antibody | Abcam | ab137078 | |
Nutrient Mix F-12 Ham's Media | Sigma-Aldrich | N6760 | |
Phorbol 12-Myristate 13-acetate | Sigma-Aldrich | P8139 | |
Pierce 16% Formaldehyde | Thermo Fisher | 28908 | |
Porcine Trypsin | Sigma-Aldrich | 85450C | |
RPMI 1640 media | Sigma-Aldrich | R8758 | |
Saponin | Sigma-Aldrich | S-7900 | |
Tissue Chopper Blade | Ted Pella | 121-6 | |
Tissue Chopper Plastic Disk | Ted Pella | 10180-01 | |
Trypsin | VWR | VWRL0154-0100 |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved